|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Bortezomib with thalidomide plus dexamethasone compared with thalido- mide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem- cell transplantation in newly diagnosed multiple myelo- ma:a randomised phase 3 study 显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
| 2 | Crystalline inclusions in plasma cell ,nyeloma显示文摘 | Patriarca C Giunta P Pasquale MD | 2007 | Int J Surg Pathol2007，15，3： | 1 |
| 3 | Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomide-dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘 | Cavo M Tacchetti P Patriarca F | 2008 | Blood2008，112，11： | 1 |
| 4 | Mycotoxin production by ahernarla strains isolated from Argentinean wheat显示文摘 | PATRIARCA A AZCARATE M P TERMINIELLO L | 2007 | Int J Food Microbiol2007，119，3： | 1 |
| 5 | A phase III study of double autotransplantation incorporating bortezomib-thalidomide-dexamethasone (VTD) or thalidomide dexamethasone (TD) for multiple myeloma:superior clinical outcomes with VTD compared to TD显示文摘 | Cavo M Tacchetti P Patriarca F | 2009 | {H}Blood2009，，22： | 1 |
| 6 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double an- tologous stem-cell transplantation in newly diagnosed multiple myelo- ma: a randomised phase 3 study 显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
| 7 | A PhaseⅢ study of double AutoTransPlantation incorporating bortezomib - thalidomide - dexam-ethasone(VTD) or thalidomide- dexameThasone (TD) for multiple myeloma:supefior clinical outcomes with VTD compared to TD显示文摘 | Cavo M Tacchetti P Patriarca F | 2009 | Blood( ASH Annu Meet Abstracts)2009，114，22： | 1 |
| 8 | On the use of rock ing chair configurations for cyclable lith ium orgamic electro lyre batteries显示文摘 | P ietro B D i Patriarca M Sero Sail B | 1982 | J Power Aources1982，，8： | 1 |
| 9 | CD138-positive plasmacytoid urothelial carcinoma of the bladder 显示文摘 | Patriarca C Di Pasquale M Giunta P | 2008 | Int J Surg Pathol2008，16，2： | 1 |
| 10 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induetion therapy before, and consolida- tion therapy after, double autologous stem-eell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 显示文摘 | CAVO M TACCHETTI P PATRIARCA F | 2010 | The Lancet2010，376，9758： | 1 |
| 11 | FluBlok, a recombinant hemag- glutinin influenza vaccine 显示文摘 | Cox M M Patriarca P A Treanor J | 2008 | Influenza and Other Respiratory Viruses2008，2，6： | 1 |
| 12 | Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomidedexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘 | Cavo M Tacchetti P Patriarca F | 2008 | Blood2008，112，11： | 1 |
| 13 | Superior complete response rate and progression-free survial after autologous transplatation with up-front Velcade-thalidomide-dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘 | CAVO M TACCHETTI P PATRIARCA F | 2008 | Blood2008，112，： | 1 |
| 14 | Myco- toxin production by Alternaria strains isolated from Argentinean wheat显示文摘 | Patriarca A Azcarate M P Terminiello L | 2007 | International Journal of Food Microbiology2007，119，3： | 1 |
| 15 | Current and universal scaling in anomalous transport显示文摘 | Goychuk Ⅰ Heinsalu E Patriarca M Schmid G Hanggi P | 2006 | Phys Rev E2006，73，02： | 1 |
| 16 | Advanced Materials Development Program for Steam Generators 显示文摘 | | 1976 | Nuclear Technology1976，28，3： | 1 |
| 17 | Evidence that elastase is the TNF-R75 shedding enzyme in resting human polymorphonuclear leukoeytes 显示文摘 | Gasparini C Menegazzi R Patriarca P | 2003 | FEBS Lett2003，553，3： | 1 |
| 18 | Evidence that elastase is the TNF-R75 shedding enzyme in resting human polymorphonuclear leukocytes 显示文摘 | Gasparini C Menegazzi R Patriarca P Dri P | 2003 | FEBS Lett2003，553，3： | 1 |
| 19 | Bortezomib with thalido-mide plus dexamethasone compared with thalidomide plus dexa- methasone as induction therapy before, and consolidation therapy after, double autologous stem-ceU transplantation in newly diag- nosed multiple myeloma: a randomized phase 3 study显示文摘 | Cavo M Tacchetti P Patriarca K | 2010 | Lancet2010，376，9758： | 1 |
| 20 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before,and consolidation therapy after,double autologous stem-cell transplantation in newly diagnosed multiple myeloma:a randomised phase 3 study显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员